People lost up to 85 pounds on Lilly’s experimental weight loss drug, company says

Eli Lilly’s highly anticipated new weight loss drug, retatrutide, helped people lose up to 30% of their body weight, about 85 pounds, in a late-stage clinical trial, the drugmaker said in a news release Thursday

Eli Lilly’s highly anticipated new weight loss drug, retatrutide, helped people lose up to 30% of their body weight, about 85 pounds, in a late-stage clinical trial, the drugmaker said in a news release Thursday.

Subscribe to read this story ad-free

Get unlimited access to ad-free articles and exclusive content.

The results are on par with bariatric surgery, which helps people lose on average 25% to 35% of their total body weight within one to two years.

“This is the largest weight loss I’ve ever seen in any medication trial,” said Dr. Susan Spratt, an endocrinologist and the senior medical director for the Population Health Management Office at Duke Health in North Carolina. She was not involved in the trial. “This is huge.”